Exit Notice

You are about to leave ClinicalTrials.gov and go to: Click here for more information about this study: A Phase 2, In-Home, Safety and Efficacy Evaluation of Episodic Administration of Open-Label Palovarotene in Subjects with Fibrodysplasia Ossificans Progressiva (FOP) URL: http://clementiapharma.com/

Click on the link to continue or return to ClinicalTrials.gov Home